Results 101 to 110 of about 3,293,378 (262)

Immunomodulating effects of My 6596, β-(p-chlorophenyl)-∝-(p-fluorobenzoyl thiomethyl)-γ-butyrolactone, a novel antirheumatic agent

, 1986
Shuichiro Kadowaki, Kumiko Sugasawa, Susumu Mizogami   +2 more
openalex   +1 more source

From Disease Control to Disease Modification: The Atopic Dermatitis Disease Activity Index

Allergy, Volume 81, Issue 2, Page 577-579, February 2026.
Thomas Bieber, Laura Maintz, Ganesh E. Phad, Marie‐Charlotte Brüggen   +3 more
wiley   +1 more source

Comparative evaluation of the effects of synthetic disease-modifying antirheumatic drugs and biological agents on clinical course, the rate of development of destructive changes, and quality of life in patients with rheumatoid arthritis

, 2019
Mazurov Vi, I. B. Belyaeva, Е. А. Трофимов, Р. Р. Самигуллина, I. V. Oktyabrskaya, М. С. Петрова, О. В. Инамова, R. A. Bashkinov   +7 more
openalex   +2 more sources

Consenso 2012 da Sociedade Brasileira de Reumatologia para o tratamento da artrite reumatoide

Revista Brasileira de Reumatologia
OBJETIVO: Elaborar recomendações para o tratamento da artrite reumatoide no Brasil. MÉTODO: Revisão da literatura com seleção de artigos baseados em evidência e opinião de especialistas da Comissão de Artrite Reumatoide da Sociedade Brasileira de ...
Licia Maria Henrique da Mota, Boris Afonso Cruz, Claiton Viegas Brenol, Ivanio Alves Pereira, Lucila Stange Rezende-Fronza, Manoel Barros Bertolo, Max Victor Carioca de Freitas, Nilzio Antonio da Silva, Paulo Louzada-Júnior, Rina Dalva Neubarth Giorgi, Rodrigo Aires Corrêa Lima, Geraldo da Rocha Castelar Pinheiro   +11 more
doaj  

Erratum to: Optimum use of disease-modifying and immunosuppressive antirheumatic agents during pregnancy and lactation [PDF]

, 1996
Rosalind Ramsey‐Goldman, Ellen Van Obberghen‐Schilling   +1 more
openalex   +1 more source

Rationales for discontinuation of disease-modifying antirheumatic drugs, biologic agents, and tofacitinib in rheumatoid arthritis

, 2018
Yu. V. Muraviev, G. I. Gridneva, L. A. Muravieva, N. V. Muravieva, A. V. Alexeeva, К. S. Nurbaeva, K. M. Mikhailov, A. V. Rozov   +7 more
openalex   +2 more sources

Medication Persistence of Disease‐Modifying Antirheumatic Drugs and Anti–Tumor Necrosis Factor Agents in a Cohort of Patients With Rheumatoid Arthritis in Brazil

Arthritis care & research, 2016
F. Acurcio, M. Machado, C. Moura, F. Ferre, A. Guerra, E. I. Andrade, M. Cherchiglia, E. Rahme   +7 more
semanticscholar   +1 more source

Prophylaxis and therapy of HBV infection in 20 patients treated with disease modifying antirheumatic drugs or with biological agents for rheumatic diseases

, 2011
Stefania Zingarelli, Paolo Airò, Micol Frassi, Chiara Bazzani, Mirko Scarsi, Massimo Puoti   +5 more
openalex   +2 more sources

Further Evidence for Influenza and Pneumococcal Vaccination in Patients Treated with Disease Modifying Antirheumatic Drugs and Anti-Tumor Necrosis Factor Agents [PDF]

, 2014
Meliha C Kapetanovic
openalex   +1 more source

Clinically used antirheumatic agent auranofin is a proteasomal deubiquitinase inhibitor and inhibits tumor growth [PDF]

, 2014
Ningning Liu, Xiaofen Li, Hongbiao Huang, Chong Zhao, Siyan Liao, Changshan Yang, Shouting Liu, Wenbin Song, Xiaoyu Lu, Xiaoying Lan, Xin Chen, Songgang Yi, Li Xu, Lili Jiang, Canguo Zhao, Xiaoxian Dong, Ping Zhou, Shujue Li, Shunqing Wang, Xianping Shi, Q. Ping Dou, Xuejun Wang, Jinbao Liu   +22 more
openalex   +1 more source